For instance, Demesteere et al. examined the effects of GnRH-a on ovarian reserve markers (FSH, AMH) in 129 patients with lymphoma and concluded that it is not effective in preventing ovarian insufficiency [11]. This evidence concerns the gene BRD2 and lymphoma.